Works matching AU Julius, Stevo


Results: 108
    1

    Syndrome X: Is it for real?

    Published in:
    Genetic Epidemiology, 1998, v. 15, n. 1, p. 19, doi. 10.1002/(SICI)1098-2272(1998)15:1<19::AID-GEPI2>3.0.CO;2-#
    By:
    • Neel, James V.;
    • Julius, Stevo;
    • Weder, Alan;
    • Yamada, Michiko;
    • Kardia, Sharon L.R.;
    • Haviland, Martha B.
    Publication type:
    Article
    2

    Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy: A Losartan Intervention For Endpoint Reduction (LIFE) Substudy.

    Published in:
    JAMA: Journal of the American Medical Association, 2002, v. 288, n. 12, p. 1491, doi. 10.1001/jama.288.12.1491
    By:
    • Kjeldsen, Sverre E.;
    • Dahlöf, Björn;
    • Devereux, Richard B.;
    • Julius, Stevo;
    • Aurup, Peter;
    • Edelman, Jonathan;
    • Beevers, Gareth;
    • de Faire, Ulf;
    • Fyhrquist, Frej;
    • Ibsen, Hans;
    • Kristianson, Krister;
    • Lederballe-Pedersen, Ole;
    • Lindholm, Lars H.;
    • Nieminen, Markku S.;
    • Omvik, Per;
    • Oparil, Suzanne;
    • Snapinn, Steven;
    • Wedel, Hans
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Regression of Electrocardiographic Left Ventricular Hypertrophy and Decreased Incidence of New-Onset Atrial Fibrillation in Patients With Hypertension.

    Published in:
    JAMA: Journal of the American Medical Association, 2006, v. 296, n. 10, p. 1242, doi. 10.1001/jama.296.10.1242
    By:
    • Okin, Peter M.;
    • Wachtell, Kristian;
    • Devereux, Richard B.;
    • Harris, Katherine E.;
    • Jern, Sverker;
    • Kjeldsen, Sverre E.;
    • Julius, Stevo;
    • Lindholm, Lars H.;
    • Nieminen, Markku S.;
    • Edelman, Jonathan M.;
    • Hille, Darcy A.;
    • Dahlöf, Björn
    Publication type:
    Article
    9

    Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Treatment and the Prediction of Major Cardiovascular Events.

    Published in:
    JAMA: Journal of the American Medical Association, 2004, v. 292, n. 19, p. 2343, doi. 10.1001/jama.292.19.2343
    By:
    • Okin, Peter M.;
    • Devereux, Richard B.;
    • Jern, Sverker;
    • Kjeldsen, Sverre E.;
    • Julius, Stevo;
    • Nieminen, Markku S.;
    • Snapinn, Steven;
    • Harris, Katherine E.;
    • Aurup, Peter;
    • Edelman, Jonathan M.;
    • Wedel, Hans;
    • Lindholm, Lars H.;
    • Dahlöf, Björn
    Publication type:
    Article
    10
    11

    Borderline Hypertension.

    Published in:
    Clinical & Experimental Hypertension, 1999, v. 21, n. 5/6, p. 741, doi. 10.3109/10641969909061004
    By:
    • Julius, Stevo
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.

    Published in:
    Blood Pressure, 2009, v. 18, n. 6, p. 348, doi. 10.3109/08037050903460590
    By:
    • Kjeldsen, Sverre E.;
    • Devereux, Richard B.;
    • Hille, Darcy A.;
    • Lyle, Paulette A.;
    • Dahlöf, Björn;
    • Julius, Stevo;
    • Edelman, Jonathan M.;
    • Snapinn, Steven M.;
    • de Faire, Ulf;
    • Fyhrquist, Frej;
    • Ibsen, Hans;
    • Lederballe-Pedersen, Ole;
    • Lindholm, Lars H.;
    • Nieminen, Markku S.;
    • Omvik, Per;
    • Oparil, Suzanne;
    • Wedel, Hans
    Publication type:
    Article
    21

    Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial.

    Published in:
    Blood Pressure, 2008, v. 17, n. 3, p. 170, doi. 10.1080/08037050802169644
    By:
    • Kjeldsen, Sverre E.;
    • Mcinnes, Gordon T.;
    • Mancia, Giuseppe;
    • Hua, Tsushung A.;
    • Julius, Stevo;
    • Weber, Michael A.;
    • Coca, Antonio;
    • Girerd, Xavier;
    • Jamerson, Kenneth;
    • Larochelle, Pierre;
    • Macdonald, Thomas;
    • Schmieder, Roland E.;
    • Anthony Schork, M.;
    • Viskoper, Reuven;
    • Widimský, Jiri;
    • Zanchetti, Alberto;
    • FOR THE VALUE TRIAL INVESTIGATORS
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    CLINICAL NEPHROLOGY - EPIDEMIOLOGY - CLINICAL TRIALS The impact of serum uric acid on cardiovascular outcomes in the LIFE study.

    Published in:
    Kidney International, 2004, v. 65, n. 3, p. 1041, doi. 10.1111/j.1523-1755.2004.00484.x
    By:
    • Høieggen, Aud;
    • Alderman, Michael H.;
    • Kjeldsen, Sverre E.;
    • Julius, Stevo;
    • Devereux, Richard B.;
    • de Faire, Ulf;
    • Fyhrquist, Frej;
    • Ibsen, Hans;
    • Kristianson, Krister;
    • Lederballe-Pedersen, Ole;
    • Lindholm, Lars H.;
    • Nieminen, Markku S.;
    • Omvik, Per;
    • Oparil, Suzanne;
    • Wedel, Hans;
    • Cong Chen;
    • Dahlöf, Björn
    Publication type:
    Article
    37
    38
    39
    40
    41

    The Effects of Losartan Compared to Atenolol on Stroke in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy. The LIFE Study.

    Published in:
    Journal of Clinical Hypertension, 2005, v. 7, n. 3, p. 152, doi. 10.1111/j.1524-6175.2005.04254.x
    By:
    • Kjeldsen, Sverre E.;
    • Lyle, Paulette A.;
    • Kizer, Jorge R.;
    • Dahlöf, Björn;
    • Devereux, Richard B.;
    • Julius, Stevo;
    • Beevers, Gareth;
    • De Faire, Ulf;
    • Fyhrquist, Frej;
    • Ibsen, Hans;
    • Kristianson, Krister;
    • Lederballe-Pedersen, Ole;
    • Lindholm, Lars H.;
    • Nieminen, Markku S.;
    • Omvik, Per;
    • Oparil, Suzanne;
    • Snapinn, Steven M.;
    • Harris, Katherine E.;
    • Wedel, Hans
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50